This activity is hosted on the site of our educational partner

You will be connecting to our educational partner, which controls its own content, practices, and other policies.

You will be connecting to our educational partner, which controls its own content, practices, and other policies.

  • Overview
  • Activity
  • Post-Test
  • Evaluation
  • Claim Credit
Turning the Tide: Applying Science to Patient Care In Treating Psoriasis, Psoriatic Arthritis, and Atopic Dermatitis

Turning the Tide: Applying Science to Patient Care In Treating Psoriasis, Psoriatic Arthritis, and Atopic Dermatitis

Format

Webcast

Time to Complete

1 hour

Released

May 29, 2019

Expires

May 31, 2020

Maximum Credits

1.00 / AMA PRA Category 1 CreditTM

Accredited Provider



This activity is provided by Forefront Collaborative.

Commercial Supporter

This activity is supported by an educational grant from Lilly.

For further information concerning Lilly grant funding, visit www.lillygrantoffice.com.

Activity Description

Fast-paced and focused on emerging science and treatment techniques, Turning the Tide is an interactive activity designed to sharpen participants’ understanding of psoriasis, psoriatic arthritis, and atopic dermatitis and equip them with forward-thinking patient-centered communication strategies. Through a combination of medical animation, TED Talks-style presentations, a clinical case study, and a discussion of patient-provider shared decision making, learners will explore disease pathophysiology, mechanisms of action of targeted therapies, evidence-based treatment recommendations, and use of decision aids. Learners will be provided access to slides and additional resources.

Intended Audience

The target audience is dermatologists. Other healthcare professionals, including rheumatologists, physician assistants, and nurse practitioners who treat patients with psoriasis, PsA, and AD, may benefit from participation in this educational activity.

Educational Objectives

Upon completion of the activity, participants should be able to:

  • Describe current models explaining pathophysiology of psoriasis and atopic dermatitis.
  • Identify mechanisms of action and effectiveness of existing and emerging targeted treatments for psoriasis and atopic dermatitis.
  • Discuss evolving treatment strategies and safety of treatments for psoriasis, psoriatic arthritis, and atopic dermatitis.
  • Engage patients with psoriatic disease or atopic dermatitis in shared decision making regarding goals of treatment, development of treatment plan, and treatment modification.

Fee Information

There is no fee for this educational activity.

Conflict Of Interest Disclosure Policy

Educational activities provided by Forefront Collaborative must demonstrate balance, independence, and scientific rigor. All those in a position to control the content of an activity must disclose all relevant financial relationship(s) with commercial interest(s)*. For this educational activity, all conflicts of interest have been resolved through peer review and revisions to ensure independence, evidence base, fair balance, and absence of commercial bias. Disclosures appear below.

*The ACCME defines a commercial interest as any entity producing, marketing, reselling, or distributing healthcare goods or services consumed by or used on patients. The ACCME does not consider providers of clinical service directly to patients to be commercial interests.

Faculty

Bruce Strober, MD, PhD
Professor
Department of Dermatology
University of Connecticut Health Center
Farmington, Connecticut

Dr. Strober discloses the following:
Consultant (honoraria): AbbVie, Almirall, Amgen, Arena, Boehringer Ingelheim, Bristol-Myers Squibb, Celgene, Dermavant, Dermira, GlaxoSmithKline, Janssen, LEO Pharma, Lilly, Medac, Meiji Seika Pharma, Menlo Therapeutics, Novartis, Ortho Dermatologics/Valeant, Pfizer, Regeneron, Sanofi Genzyme, Sebela Pharmaceuticals, Sitris, Sun Pharma, UCB
Investigator (no direct payments made to Bruce Strober, MD, PhD): AbbVie, Boehringer Ingelheim, Celgene, Galderma, GlaxoSmithKline, Janssen, Lilly, Merck, Pfizer, Sienna Biopharmaceuticals
Scientific Director (consulting fee): Corrona/NPF Psoriasis Registry
Grant support for Fellowship Program (payments to the University of Connecticut): AbbVie, Janssen, National Psoriasis Foundation

Richard Martin, MD, MA
Professor of Medicine and Rhematology
Michigan State University College of Human Medicine
East Lansing, Michigan

Dr. Martin discloses the following:
Contracted Research: AbbVie, Amgen, AstraZeneca, Lilly, Cytor

Planner Disclosure

April W. Armstrong, MD, MPH
Consultant: Novartis, Sanofi, Regeneron, Pfizer, Celgene, Modernizing Medicine, AbbVie, Lilly, Merck, and Janssen
Speaker and researcher: Lilly, AbbVie, and Janssen

Accredited Provider Disclosure

Forefront Collaborative
Christine Tebben
, has nothing to disclose in regards to financial relationship(s) with commercial interests.
Marianna Shershneva, MD, PhD, has nothing to disclose in regards to financial relationship(s) with commercial interests.

Credit

1.00

Type

AMA PRA Category 1 Credit(s)TM

Accreditation Statement

Forefront Collaborative is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Designation Statement

Forefront Collaborative designates this enduring activity for a maximum of 1.00 AMA PRA Category 1 CreditTM .  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosure of Unlabeled Use

This continuing medical education activity may include reference(s) to unlabeled or unapproved uses of drugs.

Disclaimer

The views and opinions expressed in this activity are those of the faculty and do not necessarily reflect the views or recommendations of Forefront Collaborative.

Instructions

To obtain credit, a score of 80% or better on the post-test is required. This activity is offered at no cost to participants. Please proceed with the activity until you have successfully completed this program, answered all test questions, completed the post-test and evaluation, and have received a digital copy of your credit certificate. Your online certificate will be saved on myCME within your Profile/Exam History, which you can access at any time.

If you have any questions relating to the accreditation of this activity, please contact Christine_tebben@forefrontcollab.com.

SYSTEM REQUIREMENTS

Hardware and Software Requirements
  • A computer with an internet connection
  • Internet Browser: Internet Explorer 7.x or higher, Firefox 4.x or higher, Safari 2.x or higher, or any other W3C standards compliant browser
  • Additional Software: Adobe Flash Player and/or an HTML 5 capable browser maybe required for video or audio playback. PowerPoint or Adobe Acrobat Reader may occasionally be required
Add to Queue